The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Tools for competing risks trials that allow simultaneous inference on recovery and mortality endpoints. Provides data preparation helpers, standard cumulative incidence estimators (restricted mean time gained/lost), and severity weighted extensions that integrate longitudinal ordinal outcomes to summarise treatment benefit. Methods follow Wen, Wang, and Hu (2023) Biometrics 79(3):1635-1645 <doi:10.1111/biom.13752>.
Version: | 0.1.0 |
Depends: | R (≥ 3.5) |
Imports: | dplyr, magrittr, stats, rlang, survival |
Suggests: | knitr, rmarkdown, readr, testthat (≥ 3.0.0) |
Published: | 2025-10-14 |
DOI: | 10.32614/CRAN.package.jointCompRisk |
Author: | Wenqing Zhang [aut, cre], Jiyang Wen [aut], Chen Hu [aut], Meicheng Wang [aut] |
Maintainer: | Wenqing Zhang <wzhan115 at jhu.edu> |
BugReports: | https://github.com/cathyzzzhang/jointCompRisk/issues |
License: | MIT + file LICENSE |
URL: | https://github.com/cathyzzzhang/jointCompRisk |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | jointCompRisk results |
Reference manual: | jointCompRisk.html , jointCompRisk.pdf |
Vignettes: |
Example Analysis (source, R code) Competing Risks Survival Analysis with jointCompRisk (source, R code) |
Package source: | jointCompRisk_0.1.0.tar.gz |
Windows binaries: | r-devel: jointCompRisk_0.1.0.zip, r-release: jointCompRisk_0.1.0.zip, r-oldrel: jointCompRisk_0.1.0.zip |
macOS binaries: | r-release (arm64): jointCompRisk_0.1.0.tgz, r-oldrel (arm64): jointCompRisk_0.1.0.tgz, r-release (x86_64): jointCompRisk_0.1.0.tgz, r-oldrel (x86_64): jointCompRisk_0.1.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=jointCompRisk to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.